A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

Clinical trial NCT06029257 · RECRUITING

Trial details

NCT number: NCT06029257
Sponsor: Almirall, S.A.
Status: RECRUITING
Study type: OBSERVATIONAL

Genital Psoriasis

Start date: 2023-11-14
Primary completion: 2026-03-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.